Asia-Pacific fertility Testing Devices Market – Industry Trends and Forecast to 2024

  • Surgical Devices
  • Published Report
  • Nov 2017
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Asia-Pacific America Fertility Testing Devices Market by product type By Product (Ovulation Prediction Kits {Urine-Based Ovulation Test Kits [Standard, Digital], Saliva-Based Ovulation Test Kits [Standard, Digital]}, Fertility Monitors {Saliva-Based Monitors, Urine-Based Monitors, Perspiration-Based Monitors, Others}), By purchase mode (non-prescription or OTC-based and prescription-based), By end user (homecare settings, specialty/infertility clinics, hospitals and others), By Countries (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines and Rest of APAC) – Industry Trends and Forecast to 2024

APAC Fertility Testing Devices Market is expected to reach USD 1,172.7 million by 2024 from USD 634.3 million in 2016, at a CAGR of 8.0% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The major factors driving the growth of fertility testing devices market are rising median age of first-time pregnancies in women, decreasing fertility rate in women, easy accessibility of ovulation monitors on e-commerce websites and increasing acceptance of basal body temperature-based ovulation monitors.

Market Segmentation: Asia-Pacific fertility Testing Devices Market

  • The APAC fertility testing devices market is segmented into 2 types, namely ovulation prediction kits and fertility monitors, on the basis of product type.
  • Ovulation prediction kits are further sub divided into urine-based ovulation test kits (standard urine-based ovulation test kits and digital urine-based ovulation test kits) and saliva-based ovulation test kits (standard saliva-based ovulation test kits and digital saliva-based ovulation test kits) and fertility monitors are further sub divided into saliva-based fertility monitors, urine-based fertility monitors, perspiration-based fertility monitors and other fertility monitors.
  • On the basis of purchase mode, the global fertility testing devices market is segmented into non-prescription or OTC-based and prescription-based.
  • On the basis of end user, the global fertility testing devices market is classified into hospitals, specialty/infertility clinics, homecare settings and others.

Key Drivers: Asia-Pacific fertility Testing Devices Market

  • Technological advancements will drive the growth of the APAC fertility testing devices market.
  • Major companies in Asia-pacific for fertility testing devices are Church & Dwight Co., Inc., GERATHERM MEDICAL AG, among others.

Key Points: Asia-Pacific fertility Testing Devices Market

Procter & Gamble is dominating the APAC fertility testing devices market followed by Geratherm Medical and Alere Inc. along with others such as Church & Dwight Co., Inc., Fairhaven Health, LLC, Prestige Brands Holdings, Inc., Hilin Life Products, Inc. among other companies.

  • In 2017, Japan will dominate the APAC fertility testing devices market.
  • China is expected to grow at the highest CAGR of 9.7% in the forecast period, and is expected to reach USD 294.3 million in 2024 from USD 140.2 million in 2016.
  • Based on product type, in 2017, ovulation prediction kits is expected to dominate the Asia-Pacific fertility testing devices market with 66.8% market share and is expected to reach USD 769.1 million by 2024, growing at a CAGR of 7.7% in the forecast period 2017 to 2024.

SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE